Glomerulonephritis, IGA: all 263 studies
Page 1 of 3. Open to participants first (102), then studies with results posted, then the rest; newest registration first within each.
- A Food-Effect Study of Budesonide Delayed Release Tablet (D23A) in Healthy Chinese ParticipantsNot yet recruitingNCT07897240Phase 1
- A Phase 3b Study of Participant Experience on Povetacicept Administered Via Autoinjector as Compared to Sibeprenlimab Administered Via Prefilled SyringeNot yet recruitingNCT07890909Phase 3
- A Study to Learn About the Effects of Felzartamab on the Kidneys of Adults With Immunoglobulin A Nephropathy (IgAN)Not yet recruitingNCT07889362Phase 2
- Efficacy and Safety of Obinutuzumab Beta in Primary IgA Nephropathy With Active Pathological LesionsNot yet recruitingNCT07888335Phase 4
- IBI3034 Study in Healthy Adults and Patients With Primary IgA NephropathyNot yet recruitingNCT07886476Phase 1
- A Study of the Efficacy and Safety of Zigakibart + Atrasentan in Adult Patients With Primary IgA NephropathyNot yet recruitingNCT07850752Phase 3
- To Assess the Efficacy and Safety of Utilizing Galactose-deficient IgA1 Biomarker Changes to Guide Pathogenic IgA-targeted Therapeutic StrategiesRecruitingNCT07822100Not applicable
- Mechanistic Evaluation of Atrasentan in Patients With IgA Nephropathy (IgAN)Not yet recruitingNCT07820995Phase 4
- A Phase 3 Open-Label Study of Long-term Treatment With Povetacicept in Adults With Immunoglobulin A NephropathyEnrolling by invitationNCT07807995Phase 3
- Efficacy and Safety of Mycophenolate Mofetil in Refractory IgA NephropathyNot yet recruitingNCT07785128Phase 2
- A Study to Evaluate the Effect of ARGX-121 on the Change in Proteinuria in Adult Participants With IgANRecruitingNCT07773727Phase 2
- Trial of Sibeprenlimab in Children and Adolescents With Immunoglobulin A Nephropathy (IgAN)Not yet recruitingNCT07770815Phase 3
- The MIMIGA Study is a Randomized, Double-blind, Placebo-controlled Crossover Trial Evaluating the Safety and Efficacy of SCFA vs. Placebo. Administered Orally Once Daily With Standard Care, it Aims to Prevent CKD Progression in Biopsy-proven IgA Nephropathy by Modulating the Gut Microbiome.Enrolling by invitationNCT07750249Early Phase 1
- Universal STAR-T Cell Injection in Autoimmune Kidney DiseasesNot yet recruitingNCT07746453Not applicable
- Phase II Clinical Study on the Efficacy and Safety of QLS7305 in Patients With Kidney Disease (Part A)Not yet recruitingNCT07730632Phase 2
- RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune DiseasesNot yet recruitingNCT07674147Early Phase 1
- Mediators of Loin Pain in IgA NephropathyEnrolling by invitationNCT07649538
- A Study to Determine if BHV-1400 is Effective and Safe in Adults With IgA NephropathyNot yet recruitingNCT07642050Phase 3
- A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA NephropathyRecruitingNCT07616700Phase 2
- Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular DiseasesRecruitingNCT07614477Phase 2
- Efficacy and Safety of Nefecon on Prevention of Relapse of IgA NephropathyRecruitingNCT07604311Phase 4
- CD19/BCMA UCAR-T for B Cell-Related Autoimmune DiseaseRecruitingNCT07586267Early Phase 1
- Early Application of Budesonide Enteric-coated Capsules in the Treatment of Primary IgA Nephropathy.RecruitingNCT07585981
- A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Primary IgA NephropathyRecruitingNCT07582133Phase 2
- Clinical Experience With Sparsentan in Switzerland in IgA NephropathyNot yet recruitingNCT07555301
- SLN12140 in Adult Participants With IgA Nephropathy in ChinaNot yet recruitingNCT07553494Phase 2
- A Study of JADE101 in Participants With Immunoglobulin A NephropathyRecruitingNCT07541287Phase 2
- Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune NephropathyNot yet recruitingNCT07535138Early Phase 1
- Chinese Adults With Kidney DiseaseRecruitingNCT07522099Phase 2
- Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune DiseaseRecruitingNCT07507201Early Phase 1
- A Study of YKST02 in Participants With Primary IgA NephropathyRecruitingNCT07498673Early Phase 1
- Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgANRecruitingNCT07498335Phase 3
- IgA Nephropathy Insights From Treatment Experience Among Patients Receiving Iptacopan and/or Atrasentan Using Primary Data CollectionNot yet recruitingNCT07481084
- Efficacy and Safety Study of HS-10542 for IgA NephropathyNot yet recruitingNCT07474636Phase 2
- Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgANRecruitingNCT07390123Phase 3
- A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney DiseasesNot yet recruitingNCT07389499Early Phase 1
- A Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy.RecruitingNCT07375758Phase 1/2
- The Randomized Controlled Study of Shenqi Yishen Granules in the Treatment of IgA NephropathyNot yet recruitingNCT07360002Not applicable
- A Study of SHR-2173 in Participants With Primary IgA NephropathyRecruitingNCT07354932Phase 2
- Managed Access Programs for EXV811, AtrasentanAvailableNCT07319585
- CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune DiseaseRecruitingNCT07305116Phase 1
- Identification and Characterisation of IgA With Nephritogenic Potential in IgA Deposition Nephropathies (Rep-IgAN)RecruitingNCT07295808Not applicable
- A Phase 1 Study of CLYM116 in Normal Healthy VolunteersRecruitingNCT07248865Phase 1
- A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.RecruitingNCT07203404Early Phase 1
- A Study to Assess the Effects of Zigakibart on IgA Nephropathy.RecruitingNCT07146906Phase 2
- A Study of Cizutamig in Patients With Immunoglobulin A NephropathyEnrolling by invitationNCT07135219Early Phase 1
- Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathyRecruitingNCT07074951Not applicable
- Finerenone in Patients With IgA-nephropathy: Prospective Interventional TrialRecruitingNCT07056595Not applicable
- Study of BHV-1400 in IgA NephropathyRecruitingNCT07054684Phase 1
- Clinical Study on the Efficacy and Safety of Telitacicept in the Treatment of Pediatric IgA Nephropathy or IgA Vasculitis NephritisNot yet recruitingNCT07052981Phase 3
- Nefecon and Ambrisentan in IgA NephropathyRecruitingNCT07030894Phase 4
- Study of Ravulizumab in Pediatric Participants With Primary IgANRecruitingNCT07024563Phase 3
- A Trial of HRS-5965 Capsule in Primary IgA NephropathyRecruitingNCT07014826Phase 3
- Epithelial Dysmetabolism and Renal Fibrosis in ANCA VasculitisRecruitingNCT07010250
- Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgANRecruitingNCT06994845Phase 3
- Phase 2 Study of ADX-038 in Complement-Mediated Kidney DiseaseRecruitingNCT06989359Phase 2
- Atacicept in Multiple Glomerular DiseasesRecruitingNCT06983028Phase 2
- Evaluate the Efficacy and Safety of NTQ5082 Capsules in Patients With Primary IgA NephropathyNot yet recruitingNCT06982040Phase 2
- A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the USRecruitingNCT06952426
- A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)RecruitingNCT06935357Phase 3
- RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)RecruitingNCT06926244
- Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.RecruitingNCT06858319Phase 3
- Study of CM313 in Subject With IgA NephropathyNot yet recruitingNCT06830395Phase 2
- A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with ProteinuriaRecruitingNCT06819826Phase 3
- Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgANRecruitingNCT06797518Phase 2
- Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune DiseaseRecruitingNCT06792799Early Phase 1
- A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune DiseasesNot yet recruitingNCT06774664Phase 1/2
- Raman Spectroscopy Diagnosis of Kidney DiseasesRecruitingNCT06760845
- IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy PatientsNot yet recruitingNCT06690359Early Phase 1
- Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)Not yet recruitingNCT06687174Phase 2
- Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)RecruitingNCT06676579Phase 2
- Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?RecruitingNCT06676384Phase 4
- A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA NephropathyRecruitingNCT06676007
- A Rollover Study to Evaluate the Long-Term Safety and Efficacy of AtaciceptEnrolling by invitationNCT06674577Phase 2
- Efficacy and Safety of Telitacicept in IgANRecruitingNCT06654596Not applicable
- A Study of the Effect and Safety of HS-10390 in the Treatment of Patients with Primary IgA NephropathyNot yet recruitingNCT06635772Phase 2
- Effect of Finerenone in IgA NephropathyNot yet recruitingNCT06580288Phase 3
- Efficacy and Safety of Probiotics Combined With Enteric-coated Budesonide Capsules in Patients With Primary IgA NephropathyNot yet recruitingNCT06528015Phase 4
- Study of WAL0921 in Patients With Glomerular Kidney DiseasesRecruitingNCT06466135Phase 2
- Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)Not yet recruitingNCT06454110Phase 2
- A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3GRecruitingNCT06419205Phase 2
- The Effect of OSA on Severity and Prognosis of Patients With IgANNot yet recruitingNCT06393036
- Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN StudyRecruitingNCT06350630Phase 2
- National Registry of Rare Kidney DiseasesRecruitingNCT06065852
- A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy SubjectsRecruitingNCT05942625Phase 1
- Interest of Follicular Helper Lymphocytes / Regulatory Follicular Helper Lymphocytes Ratio in IgA NephropathyRecruitingNCT05791162Not applicable
- Clinical Study of CM338 in the Treatment of Immunoglobulin A NephropathyRecruitingNCT05775042Phase 2
- Study of Telitacicept in Patients With Refractory IgA NephropathyNot yet recruitingNCT05596708Phase 2/3
- Oxford Classification and Clinical Remission After Initial Treatments in Patients With IgA NephropathyRecruitingNCT05528991
- Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKDRecruitingNCT05510323Phase 3
- Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)Enrolling by invitationNCT05248659Phase 2/3
- Correlation of Microbiome and Metabonomics With IgA NephropathyRecruitingNCT05190848
- Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular DiseasesRecruitingNCT05003986Phase 2
- The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)RecruitingNCT04858724
- A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A NephropathyRecruitingNCT04663204Phase 2
- Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.RecruitingNCT04662723Phase 4
- A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA NephropathyRecruitingNCT04557462Phase 3
- KOrea Renal Biobank NEtwoRk System TOward NExt-generation AnalysisRecruitingNCT03929887
- Registry of IgA Nephropathy in Chinese ChildrenRecruitingNCT03015974
- IgA Nephropathy Registration Initiative of High Quality (INSIGHT)RecruitingNCT03001947